TikTok Series: Progesterone in Gender Affirming Care

What’s the history of using progesterone in gender affirming care? When and how do we use it in transgender and gender diverse health?

Pearls:

  • we use bioidentical micronized!
  • most research is in menopausal cis women
  • ovaries make both estrogen and progesterone, so why don’t we include it?

QueerDoc’s sibling company is QueerCME, where we teach other healthcare prescribers about gender affirming care / HRT / hormones / transgender medicine. QueerCME has a TikTok, and occasionally, we share those videos here. Although these videos were originally designed for a clinical audience, they may also be useful for the rest of us.

Link to this TikTok video: https://www.tiktok.com/@queercme/video/7306873618900831531

If TikTok goes down again, contact us for a copy of this video!

Video Transcript

since we started talking about progesterone

let’s keep going

first let’s talk about why progesterone is like

less used in gender affirming care and the history of that

and then also

potentially the reasons why it’s somewhat

um contentious

so the reason progesterone is not in the guidelines in

wasn’t used historically in gender affirming care

is the Women’s Health Initiative

which was a study that was done about 30 years ago in postmenopausal

CIS women looking at hormone replacement um

for the prevention of cardiovascular diseases

the age and the study arm of that trial that use progesterone um

did have a statistically significant increase in VTE because of that uh

the that portion of the study was actually stopped early

now if you look at the issues with progesterone in that study

you will see that although it is statistically significant

it was a very small increase in incidences

and that overall mortality was not increased furthermore

the progesterone used in that study

is not the same progesterone we currently use in gender affirming care

which is bioidentical

so we typically use micronized

progesterone which um

all the literature to date

shows absolutely no increased risk in VTE with that form of progesterone

so because that study showed progesterone to be

quote unquote

less safe um

it was avoided

and both hormone replacement for postmenopausal CIS women

and in hormone therapy for transgender

diverse folks

and so because it was avoided

it’s not included in the publications

research and guidelines um

because it was used less typically

now here we are

30 years later

and we have a safer form of progesterone available to us and um

we have to think about

how well does research and data

and post menopausal CIS women translate into trans & gender diverse patients

and it really depends on the individual trans and gender diverse patient

what age are they

what are their pre existing health conditions um

and to really understand how to try to interpret that data

onto their individual risk

because of that history in those guidelines

we don’t have a lot of research or information about the use of progesterone

and trans and gender diverse folks

and that paucity of data has caused a lot of the major recommending bodies

and guideline writing organizations to say

we can’t make a recommendation for against it

cause we don’t have enough information um

and then if you look at the newest WPATH SOC8

they bring up a concern around breast cancer

but if you look at the reference article that they use for that

it is not actually like a meta analysis or a trial

or any kind of data that actually shows an increased incidence in breast cancer

from the use of micronized progesterone

it’s an opinion piece from a clinician who says

theoretically

the risk of breast cancers

might be higher with the use of micronized progesterone so I’m

on the side of this like

debate in gender affirming care that I’m pretty pro progesterone one

I think every individual patient should be treated as an individual like

we should be looking at their goals and discussing their goals with them and um

offering them counseling

whether or not progesterone would help reach those goals or help fit those goals

and then the individual risk and benefits for them

but in general

when I think about what I’m doing

as a prescribing clinician for trans and gender diverse patients

I’m often times trying to replicate the function of an ovary

and ovaries do make estrogen and progesterone

so physiologically

it seems a little odd to me to only do half the job um

especially when I know

I have a safer form of progesterone

that the original risk and concerns around progesterone are no longer valid

um furthermore

when I think about the physiologic function of progesterone and estrogen

at target tissues

I do remember from my medical training right

that they often actually act in opposition of each other

to create ideal tissue environments through a remodeling process

right like we see this in the level of the bone

where we have osteoclasts

osteoblasts responding to estrogen and progesterone

to remodel the bone and optimize bone health and strength

it’s the same thing in the endothelial lining of the blood vessels right

we know that estrogen and progesterone work in opposition

to keep that tissue optimally remodeled and flexible

and which helps reduce risk of cardiovascular disease

and we do see in the literature that CIS women with like

lower naturally occurring levels of progesterone

actually develop cardiovascular disease disease sooner than their peers with

more average or higher levels of progesterone

and so I have to wonder that if by doing an estrogen only

gender affirming care

if by not considering offering and including progesterone

I’m increasing the risk of osteoporosis and cardiovascular disease

for my trans and gender diverse patients as they age

this is all theory

we don’t have any evidence or literature around this

um in addition to like

that oppositional effect at target tissues

we also know that progesterone often works hand in hand with estrogen to

to bring about secondary

secondary sexual characteristics right

we know that progesterone is essential in the development of a breast tissue

to take it from the adolescent phase to the adult or mature phase right

to get from Tanner 3 to Tanner 5

it is essential for the creation of mature tissue

and a lot of patients will say they do feel like they have you know um

better breast development when we add progesterone

that’s clinical experience

that’s patient experience

it is not evidence based

if you’ve ever tried to measure a

a three dimensional

squishy object like boobs

it’s really hard

if you look at the research and literature

trying to do studies on breast and breast development and breast size

they have all these different strategies for measuring them

and none of them are very effective

um that being said

in a field where we have such a lack of evidence based information

I think clinician opinion and experience

and patient opinion and experience becomes that much more important

that doesn’t mean I don’t want us to continue to

advocate and strive for more evidence based information

of course I do

of course I want more research funded to help support my community and

and our educational knowledge but

evidence based medicine has multiple different levels of grading of information

and expert opinion is one of those levels

it is not considered the highest

is not considered you know

quote unquote the best

and we also know evidence based medicine is sometimes just wrong right

like historically

we looked a whole bunch of cholesterol levels

and so this is like the quote unquote healthy cholesterol level

and it was actually too high because we just like normed um

in average values we looked at in a specific population

and we often do a very

very bad job of diversifying our populations and being inclusive

um and so evidence based medicine

yes very important

I tend to call my work in gender affirming care evidence informed

to give that slight differentiation between

the fact that evidence based medicine is very lacking in my field

and I do my very best to stay um

on top of engaged and informed about the research and literature

but that ultimately what we’re doing is a really big blend

of that evidence and literature

my clinical experience

and the GREATER BODY of trans wisdom that exists within our community


Other QueerDoc articles about progesterone:

Two orange capsules are on a dark blue background.  One is marked with "P-1."  Text in all white caps reads "Let's talk about progesterone"

Stay In Touch With Us!

*** Disclaimer

Any of these articles are for entertainment, informational, and general educational purposes only and should not be considered to be healthcare advice or medical diagnosis, treatment or prescribing. The Content is not intended to be a substitute for professional medical care. Always seek the advice of your qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Share This Post

More To Explore

Request a free 15-minute introductory
appointment to find out more!